Clinical Trials Directory

Trials / Unknown

UnknownNCT04084912

Effect of Preoperative Steroid in Total Knee Arthroplasty

The Effect of Preoperative Steroids Injection on Pain and Oedema After Total Knee Arthroplasty . A Double -Blinded Randomized Controlled Study.

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
86 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Detect the effect of preoperative steroid injection in total knee arthroplasty on post operative: 1. pain 2. oedema 3. nausea and vomiting 4. quadriceps power 5. knee flexion 6. wound complications

Detailed description

Total knee arthroplasty has been identified as one of the most effective surgeries for knee arthritis. Many patients experience moderate to severe pain during the early postoperative period, as the surgery involves extensive bone resection and postsurgical serum levels of cytokine interleukin-6 and C-reactive protein may be elevated.Furthermore, many patients suffer postoperative nausea and vomiting after total knee arthroplasty . The inflammatory response after TKA is pronounced and a result of cumulative effects of anaesthesia and mechanical stress . Inadequate management of postoperative pain is relevant with a series of undesirable effects, including progression to a persistent pain, delayed functional recovery, increased the economic burden and patient dissatisfaction. Steroids may be associated with decreased levels of interleukin-6 and C reactive protein and may, thus, relieve the pain associated with surgery. Dexamethasone is a long-acting glucocorticoid that has been reported to inhibit peripheral phospholipase A, which decreases the pain-aggravating agents from the cyclooxygenase and lipoxygenase pathways . In addition, it reduces postoperative nausea and vomiting by exerting a central antiemetic effect by inhibiting prostaglandin synthesis and the release of endogenous opioids\[5\] . Some studies also reported potential adverse events, such as infection .

Conditions

Interventions

TypeNameDescription
DRUGDexamethasone Sodium Phosphateintravenous injection of one ampoule dexamethasone Sodium phosphate 2 ml 8 mg
DRUGSaline Solutionintravenous injection of one ampoule saline

Timeline

Start date
2020-01-01
Primary completion
2021-01-01
Completion
2021-06-01
First posted
2019-09-10
Last updated
2019-12-23

Source: ClinicalTrials.gov record NCT04084912. Inclusion in this directory is not an endorsement.